$6.36B
$196,000
0.0% of portfolio
2,195
Q4 2024
Reduced 80.77%
$855M
$129,000
0.0% of portfolio
18,573
Q4 2024
Added 20.29%
$626M
$111,000
0.0% of portfolio
4,514
Q4 2024
Added 1.67%
Lenz Therapeutics Inc Com
-
$158,000
0.0% of portfolio
-
Q4 2024
Added 20.67%
-
$420,000
0.0% of portfolio
-
Q4 2024
Reduced 14.58%
$124M
$50,000
0.0% of portfolio
33,932
Q4 2024
Reduced 9.83%
$1.42B
$109,000
0.0% of portfolio
9,116
Q4 2024
New
$47.7B
$190,000
0.0% of portfolio
317
Q4 2024
Reduced 83.0%
$4.35B
$685,000
0.0% of portfolio
3,035
Q4 2024
New
$1.49B
$182,000
0.0% of portfolio
28,314
Q4 2024
Reduced 67.37%
$24.7B
$810,000
0.0% of portfolio
469
Q4 2024
New
$17.9B
$692,000
0.0% of portfolio
9,541
Q4 2024
Reduced 88.07%
$857M
$199,000
0.0% of portfolio
7,177
Q4 2024
Reduced 50.76%
$1.4B
$461,000
0.0% of portfolio
23,313
Q4 2024
Reduced 41.43%
$459M
$199,000
0.0% of portfolio
47,805
Q4 2024
Added 25.91%
$19.4B
$692,000
0.0% of portfolio
9,071
Q4 2024
Reduced 83.68%
$1.18B
$171,000
0.0% of portfolio
13,062
Q4 2024
New
-
$43,000
0.0% of portfolio
-
Q4 2024
New
$17.6B
$496,000
0.0% of portfolio
3,209
Q4 2024
Reduced 87.23%
$13.6B
$297,000
0.0% of portfolio
6,849
Q4 2024
Reduced 85.08%
$991M
$684,000
0.0% of portfolio
36,228
Q4 2024
Added 43.51%
$1.15B
$201,000
0.0% of portfolio
2,268
Q4 2024
Reduced 6.59%
$145B
$169,000
0.0% of portfolio
2,980
Q4 2024
New
$15.9B
$623,000
0.0% of portfolio
9,242
Q4 2024
Added 175.47%
$1.31B
$503,000
0.0% of portfolio
9,166
Q4 2024
Added 6.46%
-
$125,000
0.0% of portfolio
-
Q4 2024
New
$1.01B
$857,000
0.0% of portfolio
20,270
Q4 2024
Added 116.7%
Veritone Inc Note 1.75011/1
-
$194,000
0.0% of portfolio
-
Q4 2024
New
$32.7B
$364,000
0.0% of portfolio
3,205
Q4 2024
Reduced 84.83%
$317M
$285,000
0.0% of portfolio
35,579
Q4 2024
Added 193.14%
$2.21B
$146,000
0.0% of portfolio
8,601
Q4 2024
Reduced 72.58%
$2.08B
$875,000
0.0% of portfolio
23,707
Q4 2024
Added 94.21%
$353M
$172,000
0.0% of portfolio
37,065
Q4 2024
Added 8.52%
$1.94B
$325,000
0.0% of portfolio
10,091
Q4 2024
Added 81.2%
-
$245,000
0.0% of portfolio
-
Q4 2024
Added 21.38%
$299B
$422,000
0.0% of portfolio
6,014
Q4 2024
Reduced 97.84%
$22.7B
$612,000
0.0% of portfolio
21,756
Q4 2024
Reduced 63.81%
$800M
$699,000
0.0% of portfolio
66,552
Q4 2024
Added 74.23%
$1.76B
$116,000
0.0% of portfolio
5,231
Q4 2024
Reduced 78.63%
$1.36B
$857,000
0.0% of portfolio
31,139
Q4 2024
Reduced 50.84%
$261M
$139,000
0.0% of portfolio
17,729
Q4 2024
Added 30.69%
$361M
$155,000
0.0% of portfolio
11,110
Q4 2024
Added 15.71%
$20.3B
$916,000
0.0% of portfolio
2,373
Q4 2024
Reduced 96.61%
-
$269,000
0.0% of portfolio
-
Q4 2024
New
-
$375,000
0.0% of portfolio
-
Q4 2024
New
Avadel Pharmaceuticals PLC Com
-
$492,000
0.0% of portfolio
-
Q4 2024
Added 274.56%
$8.93B
$238,000
0.0% of portfolio
5,538
Q4 2024
New
$386M
$164,000
0.0% of portfolio
11,715
Q4 2024
Added 20.23%
$17B
$541,000
0.0% of portfolio
114,577
Q4 2024
Reduced 96.18%
$789M
$371,000
0.0% of portfolio
11,503
Q4 2024
Reduced 25.5%